课题基金 / 基金详情

LONG-TERM METABOLIC ASSESSMENTS IN SUBJECTS TREATED WITH EMTRICITABINE/TENOFO

LONG-TERM METABOLIC ASSESSMENTS IN SUBJECTS TREATED WITH EMTRICITABINE/TENOFO
恩曲他滨/替诺福治疗受试者的长期代谢评估
批准号:
8174485
负责人:
ERIC S DAAR
金额:
$5.35万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-12-01 至 2010-11-30

项目摘要

项目成果

ERIC S DAAR的其他基金

相关文献

中文摘要
翻译
这个子项目是许多研究子项目中利用 资源由NIH/NCRR资助的中心拨款提供。子项目和 调查员(PI)可能从NIH的另一个来源获得了主要资金, 并因此可以在其他清晰的条目中表示。列出的机构是 该中心不一定是调查人员的机构。 这项研究的目的是了解服用尿苷补充剂(NucleomaxX)对艾滋病毒感染者是否安全,以及它是否可以逆转面部、手臂、腿部或臀部的脂肪流失。这项研究还将试图观察NucleomaxX的耐受性有多好。Nucleomax X是一种粉状营养食品补充剂,含有一种名为尿苷的物质。它是装在香包里的,需要和果汁、牛奶或水混合。NucleomaxX在欧洲被用作食品补充剂,但没有得到美国食品和药物管理局(FDA)的批准,在美国被认为是实验性药物 全国约有164人将参加这项研究。大约有20个人将在这个地点参加。
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The purpose of this study is to see if taking a uridine supplement (NucleomaxX¿) is safe in HIV-infected persons and if it will reverse loss of fat in the face, arms, legs, or buttocks. The study will also try to see how well NucleomaxX is tolerated. NucleomaxX is a powdered nutritional food supplement that contains a substance called uridine. It comes in a sachet (packet) and needs to be mixed in with juice, milk, or water. NucleomaxX is used in Europe as a food supplement but is not approved by the U.S. Food and Drug Administration (FDA) and is considered an experimental drug in the U.S About 164 people will take part in this study across the country. About 20 will take part in it at this site.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
An integrated intervention using a pill ingestible sensor system to trigger actions on multifaceted social and behavioral determinants of health among PLWH
Measuring and Monitoring Adherence to ART with Pill Ingestion Sensor System
Measuring and Monitoring Adherence to ART with Pill Ingestion Sensor System
CLINICAL TRIAL: A PHASE III COMPARATIVE STUDY OF THREE NON-NUCLEOSIDE REVERSE TR